A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets

Clinical trial NCT05660863 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05660863
Sponsor: Guangzhou Magpie Pharmaceuticals Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2025-09-01
Primary completion: 2026-03-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.